Cardiology

New data from Mount Sinai Hospital suggests anticoagulant use could improve survival rates among patients hospitalized with COVID-19.

After receiving approval for a similar indication in type 2 diabetics in late 2019, the FDA has approved dapagliflozin for reducing risk of CV death and hospitalization in patients with HFrEF.

A new analysis of two-year data from the FOURIER trial is shedding light on the impact of PCSK9 use for lowering LDL-C.

A new study from investigators in Finland found a single-lead ECG in a necklace could aid in diagnosis of AF.

A 17-year-old teen went to the ED after suffering his second syncopal episode in the last 6 months. He had shrugged off the first episode as not eating enough before a jog, but this time he hadn’t been doing anything active and his parents witnessed the syncope and what appeared to be a seizure. He reported that he had been feeling heart palpitations prior to the event. Further blood tests showed hypokalemia.

New research suggests an SBP target of 120 mmHg or less could lower risk of AFib up to 26%.

The latest scientific statement from the AHA addresses cardiovascular considerations before, during, and after pregnancy.

The AAN has released an update to their 2016 practice advisory—changing their stance on PFO closure to reduce risk of second stroke.

New research suggests childhood trauma and dysfunction could increase risk of CVD by up to 68%.

Evry will enable the imaging of COVID-19 patients in need of emergency care.

Patients who undergo emergency surgery have twice the risk for venous thromboembolism than those how have elective surgery.

An analysis of the CITU study is shedding light on the impact of e-cigarette use on arterial stiffness and vascular health.

A new analysis of the FOURIER trial is diving into whether evolocumab use could slow or prevent progression of aortic stenosis.

Australian researchers have new evidence that patients with diabetes have fewer cardiovascular events today than they did 20 years ago.  The data came from an analysis of the Freemantle diabetes study which compared people with type 2 diabetes to people without diabetes.  The results were recently published in the Journal of Clinical Endocrinology and Metabolism.

Australian researchers have new evidence that patients with diabetes have fewer cardiovascular events today than they did 20 years ago.  The data came from an analysis of the Freemantle diabetes study which compared people with type 2 diabetes to people without diabetes.  The results were recently published in the Journal of Clinical Endocrinology and Metabolism. 

Since 2005, opioid use has increased amongst older dementia patients.

Results of the study from investigators at CHOP could have real-world impact on treatment algorithms.

A prespecified subanalysis revealed evolocumab use was associated with a significant reduction in risk of MI.

Brief intermittent EEG may not have enough sensitivity for detecting potentially treatable seizures in cardiac arrest patients who required resuscitation.

New research suggests severe sleep apnea was linked to increased blood glucose levels in African-Americans.

New research from investigators in Europe is shedding light on the impact of mental stress on risk of peripheral artery disease

A new review is shedding light on the impact of becoming wealthy on a person's overall health.

Researchers say they have come up with a novel method to weave blood vessels from human tissue. In the study, which appears in the April issue of The FASEB Journal, researchers show that they can make yarn by cutting sheets of a Cell Assembled Matrix (CAM) into ribbons that can be used directly or twisted into threads. They used these threads to weave blood vessels that displayed excellent mechanical properties without the need for any synthetic scaffolding or chemical treatments.

Discussing how the ACC has responded to the ongoing outbreak and the potential lasting impact of COVID-19 on the College.

Higher dosages of chloroquine can lead to safety hazards.

An anaylsis of damaged heart valves from patients who had undergone transplants revealed a surprising finding: the process that causes aortic stenosis is different in women and men.

While stay-at-home orders have slowed the spread of COVID-19, Thomas Maddox, MD, and the ACC are concerned it may be having a dangerous secondary impact.

Discussing how COVID-19 impacts the cardiovascular health of infected patients with the Chair of the ACC's Science and Quality Committee.

New research from the RED VELVT trial is shedding further light on the discussion surrounding off-label use of DOACs for left ventricular thrombi.

New research from investigators in Poland suggests losses by a local sports team were associated with a 27% increase in acute coronary syndrome admissions.